Sera Prognostics, Inc. (SERA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...

Ever been stuck on the road far from home with a breakdown? Not fun. So imagine getting an email or text warning weeks or months before a starter quits, a battery dies or a fuel pump fails. Some of ...

View Sera Prognostics, Inc. Class A SERA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Ongoing progress in engaging Medicaid plans in targeted states with prior PreTRM clinical study experience. Notable traction in two particular states with above-average premature birth rates, ...

Aligning Management Team given New Refined Commercial Focus on Institutions Starting with Recent Appointment of Board Member Zhenya Lindgardt as Interim President and CEO Engages Leading Strategy ...

The company targets active discussions in 15–17 states and aims to run 5–7 partner programs by the end of 2026, representing 58–60% of U.S. births. Aerts explained, "We have budgeted the same -- ...

Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to provide early, pivotal pregnancy ...

Following release of full Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs ("PRIME") study results meeting primary success criteria, Sera is elevating ...